Evert B. Schimmelpennink has bought stock on 2 days since Sep 2018

Evert B. Schimmelpennink, also known as Eef, is the President, Chief Executive Officer, Secretary, and Director of LENZ Therapeutics, Inc. (LENZ), a biopharmaceutical company focused on ophthalmic pharmaceuticals, a role he has held since March 2021.( He recently engaged in insider trading at LENZ in this capacity.[user query context]

Schimmelpennink brings extensive experience in biopharmaceutical leadership, having previously served as President and CEO of Pfenex, Inc. from 2017 to 2020 until its acquisition by Ligand Pharmaceuticals, and as CEO of Alvotech from 2015 to 2017.( Earlier roles include senior positions at Pfizer Inc. as Vice President of Global Sterile Injectables, Hospira Inc. as Vice President of Global Generics, and Synthon BV as Vice President of Sales & Marketing.( He currently chairs the board of Contineum Therapeutics, Inc. since 2022 and serves as an independent director at iBio, Inc. and Pipeline Therapeutics.( Schimmelpennink holds an M.Sc. in Bioprocess Engineering from Wageningen University and a business degree from Arnhem Business School.(

Written by Perplexity from public sources.